Sensex and Nifty Trends

The benchmark Sensex opened sharply lower by 532.83 points and extended losses throughout the session, closing below its 50-day moving average (DMA). The 50 DMA itself remains below the 200 DMA, signalling a cautious medium-term technical outlook. The Nifty followed a similar trajectory, weighed down by sectoral underperformance and profit booking in heavyweight stocks. The broader market indices also reflected this cautious mood, with the S&P BSE 250 Midcap index falling 0.23% and the S&P BSE 150 Smallcap index declining 0.11%. The BSE100 index was down 0.75%, underscoring the widespread selling pressure.

Sectoral Performance: Pharma Leads, Auto Lags

Out of 38 sectors tracked, only 9 advanced while 29 declined, highlighting a broad-based weakness. The Nifty Pharma sector was the top gainer, rising 2.17%, buoyed by strong performances from select large caps such as Dr Reddy's Laboratories, which surged 7.81%. This sector strength was supported by positive global cues and anticipation of robust earnings from pharmaceutical companies.

Conversely, the auto sector was the worst performer, falling 2.22%. Key midcap auto stocks like Ashok Leyland declined 3.94%, reflecting concerns over slowing demand and rising input costs. The weakness in autos weighed heavily on the overall market sentiment, contributing to the negative close.

Top Gainers and Losers Across Market Caps

Among large caps, Dr Reddy's Laboratories led the gains with a strong 7.81% rally, supported by upbeat sectoral momentum. In the midcap space, GE Vernova T&D emerged as the top gainer, soaring 8.93%, while Praj Industries led the small caps with an 8.21% increase. These stocks benefited from sector-specific tailwinds and positive investor interest.

On the downside, Havells India was the largest large-cap loser, plunging 6.34% amid profit booking and subdued outlook. Midcap Ashok Leyland declined 3.94%, while small cap IIFL Finance was the worst performer in its category, tumbling 8.65% on profit-taking and cautious credit market sentiment. Union Bank of India also fell sharply by 6.44%, reflecting concerns over asset quality and earnings pressure.

Market Breadth and Technical Indicators

The advance-decline ratio across the BSE500 was weak at 0.59x, with 185 advances against 311 declines, signalling a lack of broad-based buying interest. Despite this, some indices such as the S&P BSE Capital Goods, Power, and Industrials indices hit new 52-week highs, indicating pockets of strength within the market. However, the overall technical picture remains cautious as the Sensex trades below key moving averages, suggesting investors are awaiting clearer directional cues.

Foreign Institutional and Domestic Investor Activity

Foreign institutional investors (FIIs) remained cautious, showing restrained buying interest amid global uncertainties and ahead of key corporate earnings scheduled for 24 Apr 2026, including Reliance Industries, Shriram Finance, and Hindustan Zinc. Domestic institutional investors (DIIs) also maintained a cautious stance, contributing to the subdued market breadth and lack of sustained buying momentum.

Global Cues and Their Impact

Global markets exhibited mixed trends, with some major indices showing resilience while others faced pressure due to concerns over inflation and geopolitical tensions. These external factors influenced domestic investor sentiment, leading to a risk-off approach in Indian equities. The cautious global backdrop, combined with domestic sectoral divergences, contributed to the overall market weakness.

Upcoming Corporate Earnings to Watch

Market participants are closely monitoring the earnings announcements due on 24 Apr 2026. Reliance Industries, a heavyweight in the index, is expected to report its quarterly results, which could provide directional cues for the broader market. Similarly, Shriram Finance and Hindustan Zinc’s results will be scrutinised for insights into the financial and metals sectors respectively. These earnings will likely influence market sentiment and sectoral performance in the near term.

Outlook and Investor Takeaways

With the Sensex trading below its 50 DMA and a subdued advance-decline ratio, the near-term outlook remains cautious. Investors should closely monitor the upcoming earnings season for confirmation of corporate performance trends. The strong showing in pharma and select capital goods sectors offers pockets of opportunity, while the auto and financial sectors require careful scrutiny given their recent underperformance.

Market participants are advised to adopt a selective approach, focusing on fundamentally strong stocks with resilient earnings prospects. The mixed global cues and domestic sectoral divergences suggest that volatility may persist until clearer macroeconomic and corporate signals emerge.

Summary

In summary, the Indian equity markets experienced a broad-based correction on 23 Apr 2026, with the Sensex falling 0.88% amid weak breadth and sectoral disparities. Pharma stocks led the gains, while autos and select financials lagged. Foreign and domestic institutional investors remained cautious ahead of key earnings announcements. Technical indicators point to a cautious stance, with the market awaiting fresh catalysts to regain momentum.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today